SWX:COPNPharmaceuticals
Cosmo (SWX:COPN) Stock Faces Trailing Loss That Tests Bullish Growth Narrative
Cosmo (SWX:COPN) has reported its H1 2026 results with trailing 12 month revenue of €102.7 million and a loss of €6.4 million, translating to an EPS loss of €0.38, while the current share price sits at CHF63.6. The company has seen revenue move from €130.6 million in H2 2024 to €52.5 million in H2 2025 on a half year basis, with EPS shifting from €3.73 to a loss of €0.10 over the same periods. This sets up a results season in which investors are weighing forecasted growth against pressure on...